Hippocratic AI
Hippocratic AI Raises $126 million in Series C
Quick Facts
Hippocratic AI Raises $126 million in Series C
Hippocratic AI has successfully raised $126 million in a Series C at a $3.5 billion valuation led by Avenir Growth.
Company Overview
Hippocratic AI is a HealthTech company headquartered in Palo Alto CA, founded in 2023 with 300+ employees.
Hippocratic AI builds non-diagnostic patient-facing clinical AI agents for healthcare. In 15 months since commercialization the company established partnerships with over 50 large health systems payors and pharma clients in 6 countries built over 1000 clinical use cases and completed over 115 million clinical patient interactions.
Fundraising Details
- Amount Raised: $126 million
- Round Type: Series C
- Valuation: $3.5 billion valuation
- Date: 2025-11-03
- Investors: Avenir Growth and CapitalG and General Catalyst and Andreessen Horowitz and Kleiner Perkins and Premji Invest
About Hippocratic AI
Hippocratic AI builds non-diagnostic patient-facing clinical AI agents for healthcare. In 15 months since commercialization the company established partnerships with over 50 large health systems payors and pharma clients in 6 countries built over 1000 clinical use cases and completed over 115 million clinical patient interactions. The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Palo Alto CA
- Founded: 2023
- Team Size: 300+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Hippocratic AI's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Hippocratic AI's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching $3.5 billion valuation marks an important milestone for Hippocratic AI, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Hippocratic AI is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-11-03. For more information about Hippocratic AI, visit their headquarters at Palo Alto CA.
Key Investors
About the Author
Related Company Reports
Harvey AI Raises $160 million in Series F
Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.
7AI Raises $130 million in Series A
7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.
TRIANA Biomedicines Raises $120 million in Series B
TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.